Catalyst Wire Dossier Catalyst Wire Dossier

Canagliflozin (Invokana)

canagliflozin · Janssen Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Canagliflozin (Invokana), covering 2016-10-06 to 2016-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants [Phase 2]

See pricing